Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
PTP4A1P5 is a **pseudogene** of the protein tyrosine phosphatase type IVA, member 1 (PTP4A1), located in the human genome. Pseudogenes are DNA sequences resembling functional genes but are generally non-coding and do not produce functional protein products. While the parent gene PTP4A1 is an important protein tyrosine phosphatase involved in cell signaling, proliferation, and cancer development[1][3][7], the pseudogene PTP4A1P5 itself is not known to have any functional or therapeutic relevance. It is not considered a drug target, and there is no evidence for biological functions, disease associations, or drug interactions specific to PTP4A1P5.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Protein tyrosine phosphatase type IVA, member 1 pseudogene 5 (PTP4A1P5).